Bumadizone
Appearance
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Vanished user 0x8cSXE0x6 (talk | contribs) at 15:34, 11 July 2017. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 15:34, 11 July 2017 by Vanished user 0x8cSXE0x6 (talk | contribs)
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.020.646 |
Chemical and physical data | |
Formula | C19H22N2O3 |
Molar mass | 326.38958 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Bumadizone, or bumazidone, is a nonsteroidal anti-inflammatory drug (NSAID).
References
pyrazolones / pyrazolidines | |
---|---|
salicylates | |
acetic acid derivatives and related substances | |
oxicams | |
propionic acid derivatives (profens) |
|
n-arylanthranilic acids (fenamates) | |
COX-2 inhibitors (coxibs) | |
other | |
NSAID combinations | |
Key: underline indicates initially developed first-in-class compound of specific group; #WHO-Essential Medicines; †withdrawn drugs; ‡veterinary use. | |
This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |
Hidden categories: